Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

Paper Submission

Views	Downloads

Relative Articles
Atopic Dermatitis
Single nucleotide polymorphism-based genome-wide linkage analysis in Japanese atopic dermatitis families
Atopic dermatitis
The pathogenesis of atopic dermatitis
Photo(chemo)therapy for Atopic Dermatitis
Therapeutical tendencies in atopic dermatitis
Advances in Atopic Dermatitis.
Efficacy Evaluation of Unique Skincare Product Containing Pseudo-Ceramide for Fine Wrinkles in Japanese Female Atopic Dermatitis Patients
Probiotics and Atopic Dermatitis in Children
Atopic Dermatitis and Homeopathy
More...

PLOS ONE 2012

ORAI1 Genetic Polymorphisms Associated with the Susceptibility of Atopic Dermatitis in Japanese and Taiwanese Populations

DOI: 10.1371/journal.pone.0029387

Full-Text Cite this paper Add to My Lib

Abstract:

Atopic dermatitis is a chronic inflammatory skin disease. Multiple genetic and environmental factors are thought to be responsible for susceptibility to AD. In this study, we collected 2,478 DNA samples including 209 AD patients and 729 control subjects from Taiwanese population and 513 AD patients and 1027 control subject from Japanese population for sequencing and genotyping ORAI1. A total of 14 genetic variants including 3 novel single-nucleotide polymorphisms (SNPs) in the ORAI1 gene were identified. Our results indicated that a non-synonymous SNP (rs3741596, Ser218Gly) associated with the susceptibility of AD in the Japanese population but not in the Taiwanese population. However, there is another SNP of ORAI1 (rs3741595) associated with the risk of AD in the Taiwanese population but not in the Japanese population. Taken together, our results indicated that genetic polymorphisms of ORAI1 are very likely to be involved in the susceptibility of AD.

References

[1]	Peinelt C, Vig M, Koomoa DL, Beck A, Nadler MJ, et al. (2006) Amplification of CRAC current by STIM1 and CRACM1 (Orai1). Nat Cell Biol 8: 771–773.
[2]	Hill PB, Hillier A, Olivry T (2001) The ACVD task force on canine atopic dermatitis (VI): IgE-induced immediate and late-phase reactions, two inflammatory sequences at sites of intradermal allergen injections. Vet Immunol Immunopathol 81: 199–204.
[3]	Olivry T, Hill PB (2001) The ACVD task force on canine atopic dermatitis (XVIII): histopathology of skin lesions. Vet Immunol Immunopathol 81: 305–309.
[4]	Vickery BP (2007) Skin barrier function in atopic dermatitis. Curr Opin Pediatr 19: 89–93.
[5]	Enomoto H, Hirata K, Otsuka K, Kawai T, Takahashi T, et al. (2008) Filaggrin null mutations are associated with atopic dermatitis and elevated levels of IgE in the Japanese population: a family and case-control study. J Hum Genet 53: 615–621.
[6]	Akdis M (2006) Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 18: 738–744.
[7]	Oh DY, Schumann RR, Hamann L, Neumann K, Worm M, et al. (2009) Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. Allergy 64: 1608–1615.
[8]	Oiso N, Fukai K, Ishii M (2000) Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 142: 1003–1006.
[9]	Rafatpanah H, Bennett E, Pravica V, McCoy MJ, David TJ, et al. (2003) Association between novel GM-CSF gene polymorphisms and the frequency and severity of atopic dermatitis. J Allergy Clin Immunol 112: 593–598.
[10]	Shimizu M, Matsuda A, Yanagisawa K, Hirota T, Akahoshi M, et al. (2005) Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 14: 2919–2927.
[11]	Takahashi N, Akahoshi M, Matsuda A, Ebe K, Inomata N, et al. (2005) Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes. Hum Mol Genet 14: 3149–3159.
[12]	Tsunemi Y, Saeki H, Nakamura K, Sekiya T, Hirai K, et al. (2002) Interleukin-13 gene polymorphism G4257A is associated with atopic dermatitis in Japanese patients. J Dermatol Sci 30: 100–107.
[13]	Wood SH, Ke X, Nuttall T, McEwan N, Ollier WE, et al. (2009) Genome-wide association analysis of canine atopic dermatitis and identification of disease related SNPs. Immunogenetics 61: 765–772.
[14]	Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, et al. (1996) Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 34: 1016–1021.
[15]	Parekh AB, Putney JW Jr (2005) Store-operated calcium channels. Physiol Rev 85: 757–810.
[16]	Chang WC, Nelson C, Parekh AB (2006) Ca2+ influx through CRAC channels activates cytosolic phospholipase A2, leukotriene C4 secretion, and expression of c-fos through ERK-dependent and -independent pathways in mast cells. FASEB J 20: 2381–2383.
[17]	Chang WC, Parekh AB (2004) Close functional coupling between Ca2+ release-activated Ca2+ channels, arachidonic acid release, and leukotriene C4 secretion. J Biol Chem 279: 29994–29999.
[18]	Gwack Y, Feske S, Srikanth S, Hogan PG, Rao A (2007) Signalling to transcription: store-operated Ca2+ entry and NFAT activation in lymphocytes. Cell Calcium 42: 145–156.
[19]	Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, et al. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179–185.
[20]	Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, et al. (2008) Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of store-operated calcium release-activated calcium channels. Nat Immunol 9: 89–96.
[21]	Hanifin J, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Dermatol Venereol (Stockh) 92: 44–47.
[22]	Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79: 351–379.
[23]	Gwack Y, Srikanth S, Oh-Hora M, Hogan PG, Lamperti ED, et al. (2008) Hair loss and defective T- and B-cell function in mice lacking ORAI1. Mol Cell Biol 28: 5209–5222.
[24]	Potier M, Gonzalez JC, Motiani RK, Abdullaev IF, Bisaillon JM, et al. (2009) Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration. FASEB J 23: 2425–2437.
[25]	Abdullaev IF, Bisaillon JM, Potier M, Gonzalez JC, Motiani RK, et al. (2008) Stim1 and Orai1 mediate CRAC currents and store-operated calcium entry important for endothelial cell proliferation. Circ Res 103: 1289–1299.
[26]	Yang S, Zhang JJ, Huang XY (2009) Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. Cancer Cell 15: 124–134.
[27]	Korkiamaki T, Yla-Outinen H, Koivunen J, Karvonen SL, Peltonen J (2002) Altered calcium-mediated cell signaling in keratinocytes cultured from patients with neurofibromatosis type 1. Am J Pathol 160: 1981–1990.
[28]	Trautmann A, Akdis M, Blaser K, Akdis CA (2000) Role of dysregulated apoptosis in atopic dermatitis. Apoptosis 5: 425–429.
[29]	Mercer JC, Dehaven WI, Smyth JT, Wedel B, Boyles RR, et al. (2006) Large store-operated calcium selective currents due to co-expression of Orai1 or Orai2 with the intracellular calcium sensor, Stim1. J Biol Chem 281: 24979–24990.
[30]	Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, et al. (2006) Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 281: 20661–20665.
[31]	Liou J, Kim ML, Heo WD, Jones JT, Myers JW, et al. (2005) STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 15: 1235–1241.
[32]	Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, et al. (2005) STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol 169: 435–445.
[33]	DeHaven WI, Smyth JT, Boyles RR, Putney JW Jr (2007) Calcium inhibition and calcium potentiation of Orai1, Orai2, and Orai3 calcium release-activated calcium channels. J Biol Chem 282: 17548–17556.
[34]	Li Z, Lu J, Xu P, Xie X, Chen L, et al. (2007) Mapping the interacting domains of STIM1 and Orai1 in Ca2+ release-activated Ca2+ channel activation. J Biol Chem 282: 29448–29456.
[35]	Chou YH, Juo SH, Chiu YC, Liu ME, Chen WC, et al. (2011) A Polymorphism of ORAI1 Gene is Associated with the Risk and Recurrence of Calcium Nephrolithiasis. Journal of Urology 185(5): 1742–6.
[36]	Wei CC, Yen JH, Juo SH, Chen WC, Wang YS, et al. (2011) Association of ORAI1 haplotypes with the Risk of HLA-B27 positive Ankylosing Spondylitis. PLos ONE 6(6): e20426.

Full-Text